Mi Y. Bahng
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects.
Journal: Drug design, development and therapy
Published: March 24, 2017
Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229).
Journal: Diabetes, obesity & metabolism
Published: August 30, 2016
The Effect of Age on the Pharmacokinetics of Udenafil in Healthy Subjects.
Journal: Journal of clinical pharmacology
Published: January 22, 2016
Population pharmacokinetic analysis to recommend the optimal dose of udenafil in patients with mild and moderate hepatic impairment.
Journal: British journal of clinical pharmacology
Published: December 10, 2015
Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects.
Journal: Drug design, development and therapy
Published: June 18, 2015
Pharmacokinetic interaction between udenafil and dapoxetine: a randomized, open-labeled crossover study in healthy male volunteers.
Journal: Drug design, development and therapy
Published: March 12, 2015
Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers.
Journal: Drug design, development and therapy
Published: October 23, 2014
Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study.
Journal: Clinical therapeutics
Published: May 09, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026